CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • CSL (ASX: CSL)
    Latest News

    Two happy scientists analysing test results.
    Healthcare Shares

    2 ASX shares in healthcare ripe to buy right now: experts

    'Positive surprises' and 'defensive exposure' make for prudent additions to a stock portfolio.

    Read more »

    Growth Shares

    3 blue chip ASX 200 shares experts say are buys

    Here are three blue chips experts rate as buys...

    Read more »

    A man sitting at his dining table looks at his laptop and ponders the CSL balance sheet and the value of CSL shares today
    Healthcare Shares

    Own CSL shares? Here's a look at the biotech's balance sheet

    CSL shares have lent investors strategic upside early in FY23.

    Read more »

    A tattoed woman holds two fingers up in a peace sign.
    Growth Shares

    2 top ASX 200 shares brokers rate as buys

    Here are two high quality ASX 200 shares...

    Read more »

    A smiling woman with a handful of $100 notes, indicating strong dividend payments
    How to invest

    Here's how much $20k invested in these ASX shares 10 years ago is worth today

    Investing in these ASX shares in 2012 could have made you rich...

    Read more »

    Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
    Healthcare Shares

    CSL shares 'well-positioned to deliver double-digit earnings growth': expert

    Blackmore Capital expects CSL’s plasma therapies and influenza vaccines to underpin a solid growth outlook.

    Read more »

    a nurse wearing a medical mask prepares a patient for a blood donation in a surgical setting.
    Healthcare Shares

    Could FY23 be a good year for the CSL share price?

    CSL could be one to watch this financial year.

    Read more »

    three young children weariing business suits, helmets and old fashioned aviator goggles wear aeroplane wings on their backs and jump with one arm outstretched into the air in an arid, sandy landscape.
    Investing Strategies

    3 ASX shares to buy in a sector suddenly soaring this month: expert

    Stocks in this industry are staging a stunning comeback in July. What is it and can the rise continue?

    Read more »

    A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
    Healthcare Shares

    Why is the CSL share price up 11% in a month?

    The CSL share price continued to climb today and is flush with green for the month. Here's why.

    Read more »

    Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
    Broker Notes

    Top brokers name 3 ASX shares to buy today

    Brokers are feeling bullish about these ASX shares...

    Read more »

    A young cool man sits in a private jet wearing headphones and casual clothing.
    Share Market News

    $264 million! The 10 highest-paid CEOs on the ASX

    Which lucky executives exercised their $1 options when the actual share price was $90?

    Read more »

    Two researchers discussing results of a study with each other.
    Healthcare Shares

    What are brokers saying about the CSL share price?

    Is it too late to buy CSL shares?

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note